Bausch Health sheds light on Valeant's troubled past

In this article:

It's been a little less than a year since Valeant pharmaceuticals became Bausch Health. It also raised its full-year profit forecast today, showing it's throwing off the legacy of its scandal-ridden predecessor. Yahoo Finance's Adam Shapiro and Julie Hyman discuss with panel.

Advertisement